Arkolith/Insider Trading/SNSE/Form 4

Peyer James

10% OwnerSensei Biotherapeutics, Inc. (SNSE) · full profile →Form 4 · filed Dec 10, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$55K
Net Open-Market Flow
-$55K
Transactions
6
5 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 9, 2025Sell(S)395$8.04$3K156K
Dec 9, 2025Sell(S)3K$7.95$21K156K
Dec 9, 2025Sell(S)446$7.92$4K155K
Dec 9, 2025Option exercise(M)395$6.40$3K156K
Dec 8, 2025Sell(S)3K$8.59$27K158K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 9, 2025Option exercise(M)395—$00

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000897069-25-001793) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML